Ellevest, Inc. Halozyme Therapeutics, Inc. Transaction History

Ellevest, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$38.53 - $51.78 $1,618 - $2,174	-42 Reduced 56.0%	33 $1,000
Q2 2022 Jul 18, 2022	BUY	$37.35 - $48.3 $485 - $627	13 Added 20.97%	75 $3,000
Q4 2021 Jan 24, 2022	SELL	$31.82 - $40.75 $2,577 - $3,300	-81 Reduced 56.64%	62 $2,000
Q3 2021 Oct 19, 2021	SELL	$38.47 - $46.42 $1,885 - $2,274	-49 Reduced 25.52%	143 $6,000
Q2 2021 Jul 13, 2021	SELL	$38.84 - $51.31 $1,281 - $1,693	-33 Reduced 14.67%	192 $9,000
Q1 2021 May 03, 2021	BUY	$39.51 - $51.45 $2,370 - $3,087	60 Added 36.36%	225 $9,000
Q4 2020 Feb 04, 2021	BUY	$25.81 - $43.62 $2,245 - $3,794	87 Added 111.54%	165 $7,000
Q3 2020 Oct 26, 2020	BUY	$25.74 - $29.63 $1,029 - $1,185	40 Added 105.26%	78 $2,000
Q2 2020 Jul 06, 2020	SELL	$16.25 - $26.81 $877 - $1,447	-54 Reduced 58.7%	38 $1,000
Q1 2020 Apr 13, 2020	BUY	$13.9 - $21.83 $194 - $305	14 Added 17.95%	92 $2,000
Q4 2019 Feb 05, 2020	BUY	$14.93 - $19.53 $1,164 - $1,523	78 New	78 $1,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.